1. Home
  2. News

News

infographic of 11 countries in FORCE-initiative

Joining a Europe-wide alliance to scale-up research on rare and hard-to-treat cancers

The Anticancer Fund is now part of FORCE, a major European initiative supporting research on rare and hard-to-treat cancers. Alongside 13 non-profit partners from 11 countries, we’re working to bring better, evidence-based treatments to patients who urgently need them.

Milestone 1000 patients in trials Anticancer Fund

More than 1.000 patients participating in Anticancer Fund clinical trials

On International Clinical Trials Day, we’ve reached a milestone: more than 1.000 patients are participating in our 7 ongoing clinical trials across 31 countries. These numbers represent more than data — they represent progress, and lives. Discover how smart research is driving change.

Brain tumour in children - U-R-Immune Glioma trial by Anticancer Fund

New clinical trial targets aggressive brain tumours in children and young adults

We started a global trial, U-R-Immune Glioma, investigating whether Immune therapy can offer an alternative treatment for children and young adults with brain tumours. In collaboration with SickKids and CHEO in Canada.

Brand-new patient-focussed website coming up in 2018

In December 2017, ACF reworked its website aimed at medical professionals and stakeholders. The updated site focusses on our mission, tools and project portfolio. For reasons of clarity, general information for patients (such as patient guides, educational articles on cancer treatments, new findings in cancer research, in the news, etc.) has been extracted from ACF’s reworked website. Instead, we will launch an additional website that is dedicated to patients only. This patient website will be a stand-alone with accessible content for patients, family members and community members. This website is scheduled for launch in early 2018. We hope you find all the information you need on the new site, and we welcome any feedback that you might have!

SAVE THE DATE - roundtable on drug repurposing at European Parliament

Leaflet about the Anticancer Fund